Linezolid is an antibiotic used to treat infections caused by Gram-positive bacteria that are resistant to other antibiotics.

The global Linezolid market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Linezolid volume and value at global level, regional level and company level. From a global perspective, this report represents overall Linezolid market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Linezolid in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Linezolid manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Hisun Pharmaceuticals USA
SLN Pharmachem
Jubilant Pharma
Actis Generics
Admiron Life Sciences
Sharon
Tetrahedron
Amoli
Hubei Fullstate Chemical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Purity:98%-99%
Purity:>99%

Segment by Application
Skin and Soft Tissue Infections
Pneumonia Infections
Others